Showing 84 Result(s)

GlycoMira Therapeutics Advances Cancer Care with Patent for First-in-Class Therapy

Salt Lake City, UT, November 04, 2024 — GlycoMira Therapeutics announced that the US Patent Office has issued a key patent, US Patent No. 12109225, covering the Company’s novel first-in-class anti-tumor therapeutic. In pre-clinical studies, GlycoMira’s lead compound, GM-1111, has been shown to significantly improve the effectiveness of radiation in reducing tumor volume, along with …

Neutrogena Unveils Game-Changing Collaboration with Top Dermatology Experts

November 04, 2024,Skillman, N.J., United States : Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establishing multi-year partnerships with Dr. Dhaval Bhanusali, renowned skincare innovator, and Dr. Muneeb Shah, the most followed dermatologist worldwide2. This …

Revolutionizing Study Design: Medidata Introduces New Solutions for Oncology and Vaccine Research

November 04, 2024,New York, United States : Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has introduced two new bundled offerings to meet the growing demands of oncology and vaccine research. Medidata Oncology Solutions and Medidata Vaccine Solutions reinforce the FDA guidance for patient-centered endpoints, adaptive …

New Era in Health and Pharma PR as GW Health Launches to Address Health Gaps in Black Communities

Jersey City, NJ, November 01, 2024 — GW Health PR, a next-generation healthcare communications agency, officially launches today with a mission to revolutionize how health and pharmaceutical companies engage with the Black community. The agency, founded by a recognized industry leader with over two decades of experience, aims to bring culturally resonant and impactful communications …